Compare OC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OC | RVTY |
|---|---|---|
| Founded | 1938 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 13.2B |
| IPO Year | N/A | N/A |
| Metric | OC | RVTY |
|---|---|---|
| Price | $120.12 | $108.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $149.92 | $113.46 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 02-23-2026 | 02-02-2026 |
| Dividend Yield | ★ 2.64% | 0.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | ★ $11,659,000,000.00 | $2,813,367,000.00 |
| Revenue This Year | N/A | $5.33 |
| Revenue Next Year | N/A | $3.03 |
| P/E Ratio | ★ N/A | $55.81 |
| Revenue Growth | ★ 21.69 | 3.37 |
| 52 Week Low | $97.53 | $81.36 |
| 52 Week High | $192.60 | $128.29 |
| Indicator | OC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 51.73 |
| Support Level | $116.88 | $110.17 |
| Resistance Level | $122.84 | $118.21 |
| Average True Range (ATR) | 3.29 | 4.19 |
| MACD | -0.55 | -0.64 |
| Stochastic Oscillator | 28.19 | 38.61 |
Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.